Do Topical Exosome Serums Rejuvenate Ageing Skin?

The most focused recent review included split-face studies, comparative trials and uncontrolled studies. Most reported improvement in at least one outcome, such as wrinkles, pigmentation, hydration, elasticity or overall appearance [2].

That pattern is encouraging, but it is not conclusive. Study methods, products, procedures and outcome measurements varied substantially. The review found low or very low certainty evidence and concluded that short follow-up and methodological problems prevent firm conclusions.

A broader 2026 meta-analysis also reported pooled improvements in skin and hair outcomes. Its authors noted that small samples, uncontrolled studies, mixed delivery methods, short follow-up and possible publication bias may overestimate benefits [3].

One randomised split-face study enrolled 28 people. Everyone received microneedling. One side of the face also received a human fat-derived stem-cell exosome-containing solution, while the other received saline. The exosome-treated side had better short-term measurements of wrinkles, elasticity, hydration and pigmentation [4].

This was a useful controlled comparison, but it was small and lasted only 12 weeks. It tested a particular product applied with a procedure that creates microchannels in the skin. It does not show that an over-the-counter serum produces the same result on intact skin.

A prospective study followed 56 adults using a platelet-derived exosome product for six weeks. Imaging showed improvements from baseline in a composite skin-health score, including wrinkles, redness, pigmentation, luminosity and colour evenness [5].

The study did not include a placebo group. A standardised skincare routine, natural variation, measurement effects or other factors could therefore explain some of the change. The manufacturer partly funded the study, and several authors were employees, founders or consultants of the company.

A later exploratory study examined skin biopsies from 20 users of the same platelet-derived product. Some cellular-senescence and telomere-damage markers decreased after 12 weeks, particularly among participants who had higher marker levels at baseline [6].

These are laboratory measurements from human skin, not proof that the serum makes someone look younger or produces a lasting health benefit. The study was small and had no placebo group.

In a non-randomised split-face study of 15 participants, both topical fat-derived exosomes and platelet-rich plasma were used after radiofrequency microneedling. Both sides improved, with no significant difference in several outcomes at six months [7].

Without a microneedling-only or vehicle control, the study cannot show how much benefit came from either biological product. It also cannot establish that the treatments are equivalent.

The current evidence does not support claims that exosome skincare reverses ageing, repairs DNA, permanently rebuilds skin or works reliably across products. Short-term changes in imaging, rating scales or molecular markers are not the same as proven reversal of biological ageing.

A 2024 systematic review described topical exosome research as preliminary. It included human and animal evidence and found only nine eligible exosome articles, reinforcing how early the field remained at that point [8].

Possibly, but the evidence is low to very low certainty. Early studies report wrinkle improvements, yet many are small, uncontrolled or combined with procedures that also affect skin [2].

Some small studies found better short-term results when an exosome-containing product was added to microneedling [4]. That does not prove that a home serum works on intact skin. The FDA also says microneedling devices are not approved to deliver topical products into the skin [9].

That has not been established for every product. Formulation, vesicle source, concentration, storage and product testing vary. Clinical improvement from one proprietary product does not prove that all marketed serums deliver intact, active vesicles into human skin.

No. Plant, platelet and stem-cell preparations come from different sources and may carry different material. Expert guidance also recommends the broader term extracellular vesicle unless exosomal origin has been confirmed [1].

The FDA says there are currently no FDA-approved exosome products [11]. How a product is regulated depends on its contents, intended use and claims.

Small studies generally report mild, temporary effects and no serious events, but they are too small and short to establish uncommon or delayed risks. Application after microneedling creates additional uncertainty because it bypasses part of the normal skin barrier.